The agreement integrates MAGENTIQ-COLO, MAGENTIQ EYE’s AI system for colonoscopy, into PENTAX Medical’s video processors. Credit: Peter Porrini/Shutterstock.com. Japan-based PENTAX Medical, part of the HOYA Group, has expanded its collaboration with MAGENTIQ EYE to increase global adoption of AI-assisted colonoscopy. The partnership, initially focused on the US, will cover Europe, the Middle East and Africa,…
WISE is permeable to O₂ and CO₂, compatible with harsh solvents, and capable of ultra-low small-molecule sorption. Credit: Axoft / Business Wire. US-based neurotechnology company Axoft has rolled out Fleuron Water Invisible Soft Elastomer (WISE), a polymer developed to minimise optical distortions during high-resolution imaging of aqueous biological samples. The new ultraviolet (UV)-curable material is…
Monogram, a home health company, overcharged Medicare through contracts with Cigna and Humana by inflating diagnostic codes, according to the Justice Department. Source link
REGENXBIO and NS Pharma are reviewing imaging and data and will decide RGX-121’s next steps after receiving FDA’s letter. Credit: Max Acronym / Shutterstock.com. REGENXBIO has reported that the US Food and Drug Administration (FDA) has placed a clinical hold on its investigational gene therapy, RGX-121 (clemidsogene lanparvovec), developed for the treatment of mucopolysaccharidosis type…
Multiple myeloma is a form of blood cancer involving abnormal proliferation of plasma cells in bone marrow. Credit: Hadayeva Sviatlana/Shutterstock.com. HaemaLogiX has treated the first patient with its KMCAR T-cell therapy as part of the Phase I KOALA clinical trial for relapsed or refractory kappa-restricted multiple myeloma. The trial is being conducted at the Peter…
The Central Florida provider manufactured fake diagnosis codes for its Medicare Advantage patients from 2020 to 2024, the DOJ said. Humana bought The Villages Health last year. Source link
Precision Medicine Group will operate within McKesson once the transaction receives final regulatory and closing approvals. Credit: Piotr Swat / Shutterstock.com. US-based healthcare services provider McKesson has agreed to buy Precision Medicine Group for $2.25bn. McKesson believes that the deal will support its clinical research and biopharmaceutical commercialisation services. Discover B2B Marketing That Performs Combine…
The all-cash deal is expected to close next month, after which Headspace’s wellness services will live under the same roof as Sword's virtual care platform, according to a filing with Massachusetts regulators. Source link
Researchers estimate that independent dispute resolution has created $22 billion in unnecessary spending. But that estimate is flawed, argue associations representing anesthesiologists, radiologists and ER doctors. Source link
Senhwa develops cancer therapies and advances a pipeline with CX-5461, CX-4945 for solid tumours and haematological malignancies. Credit: Sai Thaw Kyar / Shutterstock.com. Senhwa Biosciences has completed enrolment in its Phase Ib expansion trial of pidnarulex (CX-5461) as a monotherapy for people with advanced solid tumours carrying breast cancer gene 1/2 (BRCA1/2) or partner and…
